Yapay Zeka Hızlı Bakış & Çıkarımlar
AI InsightAn abundance of bioactive molecules in ASB were revealed via GC-MS analysis, many of which have been previously associated with anticancer activities.CONCLUSIONOverall, Allium sativum has significant antitumoral and antimotility effects on MDA-MB-231 and MCF-7 human breast cancer cells which are attributed to its bioactive molecules.
📌 3 Maddede Bu Makale
Özet
BACKGROUND/AIMSAllium sativum (garlic) has been used as a medicinal herb for centuries, and commonly among cancer patients as herbal supplements. The aim of this study is to explore the in vitro antitumoral effects of Allium sativum L. (ASB) on human breast cancer (BCa) cell lines, MCF-7 and MDA-MB-231.MATERIAL and METHODSTrypan blue assay and LDH assays were used to quantitatively determine the cytotoxicity effects of ASB extract on BCa cell lines. Cy-totoxicity experiments were followed up by caspase-3 and -9 activity assays to get a mechanistic insight into the associated molecular pathways. The MTT assay was used to demonstrate the antiproliferative activity, whereas the lateral motility assay was used to gain insight into the migration potential of BCa cells upon incubation with the ASB extract. The bioactive molecules in the ASB extract were delineated through GC-MS analysis.RESULTSExposure to ASB extract caused a significant cytotoxicity effect on MCF-7 and MDA-MB-231 cell lines. A significant activation of caspase-9 was observed in both tested cell lines, indicating that the cytotoxic activity is mediated in an apoptotic manner. The results of the MTT assay revealed a significant antiproliferative effect on both tested cell lines at all tested time points. The lateral motility ex-periments showed a significant reduction in BCa cell motility demonstrating the antimotility potency of the ASB extract. An abundance of bioactive molecules in ASB were revealed via GC-MS analysis, many of which have been previously associated with anticancer activities.CONCLUSIONOverall, Allium sativum has significant antitumoral and antimotility effects on MDA-MB-231 and MCF-7 human breast cancer cells which are attributed to its bioactive molecules.